NDC 64850-501 – Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate

Dextroamphetamine Saccharate 1.875 mg/1; Amphetamine Aspartate Monohydrate 1.875 mg/1; Dextroamphetamine Sulfate 1.875 mg/1; Amphetamine Sulfate 1.875 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CII

Product NDC64850-501

Product details

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Generic name
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Labeler
Elite Laboratories, Inc.
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA211352
Marketed since
December 29, 2022
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate →

Package NDC codes (3)

Package NDCDescriptionSince
64850-501-01100 TABLET in 1 BOTTLE (64850-501-01)Dec 29, 2022
64850-501-05500 TABLET in 1 BOTTLE (64850-501-05)Dec 29, 2022
64850-501-3030 TABLET in 1 BOTTLE (64850-501-30)Dec 29, 2022

Other Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate products